Mereo BioPharma Group (Mereo BioPharma Group) Other Operating Expense : $-1.28 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Mereo BioPharma Group Other Operating Expense?

Mereo BioPharma Group's Other Operating Expense for the six months ended in Dec. 2023 was $-1.28 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.28 Mil.

Mereo BioPharma Group's quarterly Other Operating Expense increased from Dec. 2022 ($-1.73 Mil) to Jun. 2023 ($0.00 Mil) but then declined from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($-1.28 Mil).

Mereo BioPharma Group's annual Other Operating Expense declined from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($-1.73 Mil) but then increased from Dec. 2022 ($-1.73 Mil) to Dec. 2023 ($-1.28 Mil).

Mereo BioPharma Group Other Operating Expense Historical Data

The historical data trend for Mereo BioPharma Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group Other Operating Expense Chart

Mereo BioPharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-1.73

-1.28

Mereo BioPharma Group Semi-Annual Data
	Jun15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial												-	-	-1.73	-	-1.28

Mereo BioPharma Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.28 Mil.

Mereo BioPharma Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mereo BioPharma Group (Mereo BioPharma Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (NAS:MREO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

MAH0:Germany MAH0:Germany

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.